Sequence of Events
- The Company had scheduled a Board of Directors meeting on Saturday, 30th May, 2026 for consideration and approval of Standalone Audited Financial Results for Q4 and year ended 31st March, 2026.
- Due to medical exigency of the Statutory Auditor, the Statutory Auditor's Report could not be made available within the prescribed timeline.
- Consequently, the Financial Results could not be placed before the Board of Directors for consideration and approval within the prescribed timeline.
- The Board meeting was rescheduled to Tuesday, 2nd June, 2026, and this change was duly intimated to the Stock Exchange.
- The Company subsequently considered and approved the Standalone Audited Financial Results for the period and submitted them to the Stock Exchange.
Regulatory Compliance Statement
The Company regrets the delay and assures that adequate measures have been implemented to ensure timely compliance with applicable provisions of SEBI (LODR) Regulations, 2015.